Lung Cancer
Volume 66, Issue 3 , Pages 338-343, December 2009

Adenocarcinoma has an excellent outcome with pemetrexed treatment in Korean patients: A prospective, multicenter trial

  • Hui-Young Lee

      Affiliations

    • Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon 200-722, Republic of Korea
  • ,
  • Myung-Ju Ahn

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Republic of Korea
  • ,
  • Yeon Hee Park

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Republic of Korea
  • ,
  • Jin Seok Ahn

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Republic of Korea
  • ,
  • Bong-Seog Kim

      Affiliations

    • Division of Hematology/Oncology, Department of Internal Medicine, Seoul Veterans Hospital, Seoul 134-791,Republic of Korea
  • ,
  • Hoon Kyo Kim

      Affiliations

    • Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon 442-723, Republic of Korea
  • ,
  • Heung Tae Kim

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang 410-769, Republic of Korea
  • ,
  • Hun Mo Ryoo

      Affiliations

    • Division of Hematology-Oncology, Department of Internal Medicine, Daegu Catholic University College of Medicine, Daegu 705-718, Republic of Korea
  • ,
  • Sung Hwa Bae

      Affiliations

    • Division of Hematology-Oncology, Department of Internal Medicine, Daegu Catholic University College of Medicine, Daegu 705-718, Republic of Korea
  • ,
  • Seung Sei Lee

      Affiliations

    • Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 110-746,Republic of Korea
  • ,
  • Kwon Choi

      Affiliations

    • Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 110-746,Republic of Korea
  • ,
  • Dae-Sik Hong

      Affiliations

    • Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Bucheon 420-767, Republic of Korea
  • ,
  • Kyung Hee Lee

      Affiliations

    • Department of Internal Medicine, Yeungnam University College of Medicine, Daegu 705-717, Republic of Korea
  • ,
  • Jung Hye Kwon

      Affiliations

    • Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University School of Medicine, Seoul 134-701, Republic of Korea
  • ,
  • In Shil Choi

      Affiliations

    • Department of Internal Medicine, Seoul Municipal Boramae Hospital, Seoul National University School of Medicine, Seoul 156-707, Republic of Korea
  • ,
  • Byung-Su Kim

      Affiliations

    • Department of Internal Medicine, Seoul Municipal Boramae Hospital, Seoul National University School of Medicine, Seoul 156-707, Republic of Korea
  • ,
  • Nam Su Lee

      Affiliations

    • Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul140-743, Republic of Korea
  • ,
  • Soo Jung Gong

      Affiliations

    • Department of Internal Medicine, Eulji University School of Medicine, Daejon 302-799, Republic of Korea
  • ,
  • Keunchil Park

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Republic of Korea
    • Corresponding Author InformationCorresponding author at: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. Tel.: +82 2 3410 3459; fax: +82 2 3410 1754.

Received 24 December 2008; received in revised form 12 February 2009; accepted 15 February 2009. published online 19 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(09)00106-8

doi:10.1016/j.lungcan.2009.02.008

Lung Cancer
Volume 66, Issue 3 , Pages 338-343, December 2009